The Wall Street Journal (7/17, Dooren,
Subscription Publication) reports that Hospira Inc. has recalled several lots
of four cancer drugs due to an issue with the vials that contain the
medications, according to the drugmaker and the Food and Drug Administration.
Reuters (7/16, Sherman) reported that the
medications involved in the recall are carboplatin, cytarabine, paclitaxel, and
methotrexate.
MedPage Today (7/17, Petrochko) reports that
apparently there is a "defect in the glass vials resulting in visible
particulate matter." According to MedPage Today, "The affected glass
vials have particles embedded in the neck of the vial that may become
dislodged, the FDA said in a statement. If injected, the debris can cause
bleeding, bruising, inflammation, itching, rash, chest pain, and respiratory
symptoms."
The Boston Business Journal (7/16, Donnelly,
Subscription Publication) reported, "Hospira says it has not yet had
reports of any adverse events resulting from the foreign particles."
No comments:
Post a Comment